CPIXCumberland Pharmaceuticals Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 13700
Ticker: CPIX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2009-08-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: CPIX

Detail

Enriched 2026-08-14 20:47

Market cap: $118,516,376.37
Shares outstanding (class): 14,983,107
Shares outstanding (weighted): 14,983,107
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 93
Location: NASHVILLE,, TN
Homepage: https://www.cumberlandpharma.com
Description: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Market cap and share counts drift.

Funds holding this security

10 funds · 10 positions · $1.80M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$893.1K	0.00%	274,814 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$446.1K	0.52%	137,268 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$282.6K	0.00%	86,945 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$81.3K	0.07%	25,000 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$74.4K	0.01%	22,896 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$9.1K	0.00%	2,800 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$4.8K	0.00%	1,488 NS	FIGI
AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust	—	$4.8K	0.00%	1,468 NS	FIGI
Small Cap Opportunities Trust John Hancock Variable Insurance Trust	—	$3.1K	0.00%	956 NS	FIGI
JNL/DFA U.S. Core Equity Fund JNL Series Trust	—	$2.9K	0.00%	900 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCPIX
FIGI_COMPOSITEBBG000R93GV7
FIGI_SHARE_CLASSBBG001STBRH3
CIK0001087294
ISINUS2307701092
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Cumberland Pharmaceuticals is a pharmaceutical company, fitting the healthcare sector and pharmaceuticals industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.